Methicillin-resistant (MRSA) infections are increasingly causing morbidity and mortality; thus, drugs with multifunctional efficacy against MRSA are needed. We extracted a novel compound from the halophilic using an ethyl acetate (HPAEtOAcE). followed by purification and structure elucidation through HPLC, LCMS, and H and C NMR, revealing the novel 5-(1-indol-3-yl)-4-pentyl-1,3-oxazole-2-carboxylic acid (Compound ).
View Article and Find Full Text PDF